| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 05/02/2001 | EP1094808A1 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone |
| 05/02/2001 | EP1094798A2 INHIBITORS OF TYPE 5 AND TYPE 3 17beta-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 05/02/2001 | EP0750502B1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 05/02/2001 | CN1293568A Lipophilic microparticles containing protein drug or antigen and formulation comprising same |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225308 Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy |
| 05/01/2001 | US6225300 TNF receptor and steroid hormone in a combined therapy |
| 05/01/2001 | US6225284 Somatostatin peptides |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029178A2 Epo primary response gene 1, eprg1 |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029086A1 Peptides having corticotropin releasing factor (crf) antagonist activity |
| 04/26/2001 | WO2001029079A1 IMMUNO-INTERACTIVE FRAGMENTS OF THE αC SUBUNIT OF INHIBIN |
| 04/26/2001 | WO2001029070A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | WO2001029044A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | WO2001028978A1 Bicyclic amino acids as pharmaceutical agents |
| 04/26/2001 | WO2001028591A2 Injection vehicle for polymer-based formulations |
| 04/26/2001 | WO2001028356A2 Food supplement for increasing lean mass and strength |
| 04/26/2001 | WO2000064486A3 Enzymatically activated polymeric drug conjugates |
| 04/26/2001 | WO2000055125A3 N-cyanomethyl amides as protease inhibitors |
| 04/26/2001 | WO2000049050A3 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type |
| 04/26/2001 | US20010000473 Calcium channel antagonist possessing an inhibitory action against secretion of parathyroid hormones and a use thereof |
| 04/26/2001 | CA2389317A1 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 04/26/2001 | CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/25/2001 | EP1094072A1 Peptides having corticotropin releasing factor (CRF) antagonist activity |
| 04/25/2001 | EP1093819A2 Compounds and compositions for delivering active agents |
| 04/25/2001 | EP1093816A2 Use of ST1435 in hormonal therapy by transdermal application |
| 04/25/2001 | EP1093361A1 Plaster which contains steroids, and a method for the production and use thereof |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292707A Anhydrous topical skin preparation |
| 04/24/2001 | US6221913 Dialkyl ureas as calcitonin mimetics |
| 04/24/2001 | US6221911 Reducing subcutaneous fat deposits in a subject; improving the skin condition of a subject |
| 04/24/2001 | US6221837 Form complexes with zinc++, comprising an insulin hexamer and approximately 5 to 9 mol of zinc++ per hexamer. |
| 04/24/2001 | US6221616 Detecting modulators of receptor binding protein; incubate cells with modulators and monitoring reduction in binding activity at receptor |
| 04/24/2001 | US6221613 Utilizing competitive binding to detect preferential modulator activity on receptor binding protein; incubate cells with modulators and monitor binding, detect amplification or reduction of binding to receptors |
| 04/24/2001 | CA2220055C Dipeptides which promote release of growth hormone |
| 04/19/2001 | WO2001027273A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027254A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | WO2001027086A1 Tetrahydroquinoline derivatives |
| 04/19/2001 | WO2001026652A1 Fab i inhibitors |
| 04/19/2001 | WO2001026603A2 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 04/19/2001 | WO2000068380A3 Extracellular matrix and adhesion-associated proteins |
| 04/19/2001 | CA2387231A1 Human galanin family proteins and polynucleotides encoding the same |
| 04/19/2001 | CA2387146A1 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 04/19/2001 | CA2383650A1 Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| 04/18/2001 | EP1091738A1 BICYCLIC sPLA 2 INHIBITORS |
| 04/18/2001 | EP0843678B1 1,9-diazabicyclo[4.3.0]nona-3,8-diene derivatives |
| 04/18/2001 | CN1291994A New salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-2-(methylcarbamoyl)-2-phenylethyl) carbamoyl)-2-(2-naphtyl) ethyl) amide |
| 04/17/2001 | US6218409 Administering insulin sensitivity enhancer in combination with an aldose reductase inhibitor for reducing side effects of diabetic drugs |
| 04/17/2001 | US6217881 Vaccine |
| 04/17/2001 | CA2157003C Hormone replacement therapy |
| 04/12/2001 | WO2001025486A1 Methods for identifying rna binding compounds |
| 04/12/2001 | WO2001025269A2 Human g-protein coupled receptor |
| 04/12/2001 | WO2001025252A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | WO2001025237A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | WO2001025207A1 Novel nicotinonitrile compounds |
| 04/12/2001 | WO2001025204A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | WO2001025188A1 Novel carbamates and ureas |
| 04/12/2001 | WO2001024823A1 Cd40 antagonist for treating psoriasis |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024764A2 Cell targeting compositions and methods of using the same |
| 04/12/2001 | WO1999057117A3 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386377A1 Cell targeting compositions and methods of using the same |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/11/2001 | EP1090643A1 Remedies for hypercalcemic crisis |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1089968A1 Thyroid hormone analogues and methods for their preparation |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/10/2001 | US6214882 Benzenesulphonamide derivatives, preparation thereof and therapeutical uses thereof |
| 04/10/2001 | US6214848 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action for prophylaxis and treatment of diabetes; depressing diabetic hyperglycemia |
| 04/10/2001 | US6214798 Polypeptides |
| 04/05/2001 | WO2001023584A1 Human ubiquitin protease |
| 04/05/2001 | WO2001023546A1 37 human secreted proteins |
| 04/05/2001 | WO2001023402A1 43 human secreted proteins |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 04/05/2001 | WO2001022987A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | WO2001022982A2 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 04/05/2001 | WO2001022937A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | WO2001006015A8 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 04/05/2001 | WO2000073450A3 Cytoskeleton-associated proteins |
| 04/05/2001 | WO2000066103A3 Contraceptive compositions containing cyclic urea and amide derivatives |
| 04/05/2001 | WO2000059897A3 Esters and carbonates of 2-(4-hydroxyphenyl)-6(or 5)-hydroxy-benzothiophene derivatives as selective estrogenic compounds |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385169A1 43 human secreted proteins |
| 04/05/2001 | CA2384731A1 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 04/05/2001 | CA2384659A1 37 human secreted proteins |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1087989A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |